Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Entrada Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 7 filings
- 4 insiders, $5.92M in total
- Insiders trading
- 4
- Net value
- −$5.92M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Entrada Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| MPM Bioventures 2018, L.P. | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2018 GP LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2018 LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| Gadicke Ansbert | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| Evnin Luke | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| Foley Todd | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2014, L.P. | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2014 (B), L.P. | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM Asset Management Investors BV2014 LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM Bioventures 2018 (B), L.P. | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM Asset Management Investors BV2018 LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2014 LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| MPM BioVentures 2014 GP LLC | 10% Owner | 3,885,115Indirect | Sep 9, 2026 | 4 |
| Doshi Dipal | CEO | 517,290 | Sep 3, 2026 | 2 |
| Dowden Nathan J | President & COO | 196,060 | Sep 3, 2026 | 4 |
| Sethuraman Natarajan | President, Research & Develop. | 214,238 | Sep 3, 2026 | 3 |
| Wentworth Kory James | Chief Financial Officer | 117,277 | Sep 3, 2026 | 6 |
| Parmar Kush | Director | 2,691,337Indirect | Aug 10, 2026 | 4 |
| Rocklage Scott M | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| Schwab Andrew J. | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| 5AM Ventures V, L.P. | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| 5AM Opportunities I, L.P. | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| 5AM Partners V, LLC | 10% Owner | 2,783,781 | Aug 10, 2026 | 3 |
| Kim Peter S | Director | 117,412 | Jun 12, 2026 | 1 |
| Thistle Mary | Director | – | Jun 12, 2026 | 1 |
| Zeiher Bernhardt G | Director | 5,000Indirect | Jun 12, 2026 | 2 |
| Chapman Gina | Director | – | Jun 12, 2026 | 1 |
| Radhakrishnan Maha | Director | – | Jun 12, 2026 | 1 |
| Baker Julian | 10% Owner | 4,691,392Indirect | Nov 24, 2025 | 2 |
| Baker Felix | 10% Owner | 4,691,392Indirect | Nov 24, 2025 | 2 |
| Baker Bros. Advisors LP | 10% Owner | 4,691,392Indirect | Nov 24, 2025 | 2 |
| Baker Bros. Advisors (GP) LLC | 10% Owner | 4,691,392Indirect | Nov 24, 2025 | 2 |
| Kreher Nerissa | Chief Medical Officer | 40,037 | Sep 6, 2023 | 0 |
| Crowley John F | Director | 5,000 | Jun 12, 2023 | 0 |
| Nuechterlein Carole | Director | – | Jun 6, 2022 | 0 |
| Roche Holding Ltd | 10% Owner | 2,813,525Indirect | Nov 4, 2021 | 0 |
| Roche Finance Ltd | 10% Owner | 2,813,525Indirect | Nov 4, 2021 | 0 |
| Redmile Group, LLC | 10% Owner | 1,954,420Indirect | Nov 4, 2021 | 0 |
| Green Jeremy | 10% Owner | 1,954,420Indirect | Nov 4, 2021 | 0 |
| Redmile Biopharma Investments III, L.P. | 10% Owner | 1,954,420Indirect | Nov 4, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2025 (view filing)5:25 PM ET | Jul 9 | 2 days | Rocklage Scott M and 5 others10% Owner | SSale | −20.1K | $7.50 | −$150.5K | −0.6%3.16M after | |
| Jul 11, 2025 (view filing)5:25 PM ET | Jul 9 | 2 days | Rocklage Scott M and 5 others10% Owner | SSale | −6.93K | $7.50 | −$52.0K | −0.6%1.09M after | |
| Nov 12, 2025 (view filing)5:34 PM ET | Nov 10-12 | 2 days | Baker Julian and 3 others10% Owner | PPurchase | +178.0K | $7.60 | +$1.35M | +4.0%4.66M after | 12 lots |
| Nov 18, 2025 (view filing) | Nov 14 | 4 days | Parmar KushDirector, 10% Owner | SSale | −200.0K | $8.80 | −$1.76M | −6.3%2.96M after | |
| Nov 18, 2025 (view filing)4:34 PM ET | Nov 14 | 4 days | Rocklage Scott M and 5 others10% Owner | SSale | −200.0K | $8.80 | −$1.76M | −6.3%2.96M after | Duplicate filing |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Wentworth Kory JamesChief Financial Officer | SSale | −8.91K | $9.98 | −$88.9K | −7.5%110.0K after | 10b5-1 |
| Nov 24, 2025 (view filing)4:09 PM ET | Nov 20 | 4 days | Baker Julian and 3 others10% Owner | PPurchase | +28.9K | $9.07 | +$261.8K | +0.6%4.69M after | 4 lots |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Wentworth Kory JamesChief Financial Officer | SSale | −7.99K | $12.25 | −$97.9K | −5.5%138.0K after | 10b5-1 |
| Mar 11, 2026 (view filing) | Mar 9-10 | 2 days | Wentworth Kory JamesChief Financial Officer | SSale | −16.5K | $13.01 | −$214.4K | −11.9%121.5K after | 2 lots10b5-1 |
| Mar 11, 2026 (view filing) | Mar 9-10 | 2 days | Dowden Nathan JPresident & COO | SSale | −15.0K | $13.04 | −$195.8K | −7.0%198.6K after | 2 lots10b5-1 |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Wentworth Kory JamesChief Financial Officer | SSale | −2.50K | $12.95 | −$32.4K | −2.1%119.0K after | 10b5-1 |
| May 4, 2026 (view filing) | May 4 | Same day | Dowden Nathan JPresident & COO | SSale | −15.0K | $15.33 | −$229.9K | −7.0%198.6K after | 10b5-1 |
| May 4, 2026 (view filing) | May 4 | Same day | Sethuraman NatarajanPresident, Research & Develop. | SSale | −25.9K | $15.39 | −$398.7K | −10.7%216.3K after | 10b5-1 |
| May 21, 2026 (view filing) | May 20 | 1 day | Zeiher Bernhardt GDirector | PPurchase | +5.00K | $5.86 | +$29.3K | New position5.00K after | |
| Aug 3, 2026 (view filing)5:26 PM ET | Jul 30-31 | 4 days | Parmar KushDirector, 10% Owner | SSale | −116.5K | $6.93 | −$807.0K | −3.9%2.85M after | 2 lots |
| Aug 3, 2026 (view filing)5:32 PM ET | Jul 30-31 | 4 days | Rocklage Scott M and 5 others10% Owner | SSale | −116.5K | $6.93 | −$807.0K | −3.9%2.85M after | 2 lotsDuplicate filing |
| Aug 10, 2026 (view filing)7:52 PM ET | Aug 6-7 | 4 days | Rocklage Scott M and 5 others10% Owner | SSale | −62.8K | $6.88 | −$431.8K | −2.2%2.78M after | 2 lots |
| Aug 10, 2026 (view filing)7:54 PM ET | Aug 6-10 | 4 days | Parmar KushDirector | SSale | −155.3K | $6.95 | −$1.08M | −5.5%2.69M after | 3 lots |
| Aug 26, 2026 (view filing)9:27 PM ET | Aug 24-26 | 2 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −62.7K | $7.36 | −$461.5K | −1.4%4.32M after | 3 lots |
| Aug 26, 2026 (view filing)9:28 PM ET | Aug 24-26 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −62.7K | $7.36 | −$461.5K | −1.4%4.32M after | 3 lotsDuplicate filing |
| Aug 31, 2026 (view filing)6:25 PM ET | Aug 27-31 | 4 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.9K | $7.08 | −$615.8K | −2.0%4.23M after | 3 lots |
| Aug 31, 2026 (view filing)6:26 PM ET | Aug 27-31 | 4 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −86.9K | $7.08 | −$615.8K | −2.0%4.23M after | 3 lotsDuplicate filing |
| Sep 3, 2026 (view filing)7:21 PM ET | Sep 1-3 | 2 days | Gadicke Ansbert and 9 others10% Owner | SSale | −86.5K | $7.14 | −$617.4K | −2.0%4.14M after | 3 lots |
| Sep 3, 2026 (view filing)7:21 PM ET | Sep 1-3 | 2 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −86.5K | $7.14 | −$617.4K | −2.0%4.14M after | 3 lotsDuplicate filing |
| Sep 9, 2026 (view filing)7:23 PM ET | Sep 4-9 | 5 days | Gadicke Ansbert and 9 others10% Owner | SSale | −259.8K | $7.33 | −$1.91M | −6.3%3.89M after | 3 lots |
| Sep 9, 2026 (view filing)7:24 PM ET | Sep 4-9 | 5 days | MPM Bioventures 2018, L.P. and 2 others10% Owner | SSale | −259.8K | $7.33 | −$1.91M | −6.3%3.89M after | 3 lotsDuplicate filing |